LY3537031

LY3537031 是目前在国外临床研究中出现的一款新药或疗法，主要研究方向为Alcohol Use Disorder。下面汇总了它当前在全球正在招募患者的研究，以及中国患者可以走的申请途径。

正在招募患者的 LY3537031 研究

• A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

  II 期招募中美国ArgentinaBrazil加拿大NCT07219173

• A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

  II 期招募中美国Argentina奥地利加拿大NCT07759245

• A Study of Brenipatide in Participants With Alcohol Use Disorder

  III 期招募中美国比利时中国德国NCT07219953

• A Study of Brenipatide in Adult Participants With Major Depressive Disorder

  III 期招募中美国澳大利亚Brazil加拿大NCT07412756

• A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse

  II 期招募中美国中国日本NCT07223840

• A Study of the Pharmacokinetics and Safety of LY3537031 in Participants With Normal Liver Function and With Mild, Moderate, or Severe Liver Impairment

  I 期招募中Hungary新西兰SlovakiaNCT07165002

• A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)

  II 期招募中美国比利时加拿大中国NCT07545772

• A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)

  II 期招募中美国比利时加拿大中国NCT07545759

• A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)

  II 期招募中美国ArgentinaBrazil中国NCT07286175

• A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder

  III 期招募中美国澳大利亚Brazil加拿大NCT07775300

• A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder

  III 期招募中美国比利时中国德国NCT07219966

• A Study of Brenipatide in Participants With Opioid Use Disorder

  II 期招募中美国加拿大Puerto Rico英国NCT07420283

• A Study of Brenipatide in Adult Participants With Schizophrenia

  II 期招募中美国ArgentinaBrazil中国NCT07410507

本页信息整理自 ClinicalTrials.gov 公开登记数据，仅供参考，不构成医疗建议；是否适合使用该药物，请以专业医生和研究团队的意见为准。